The $1.5 million contract to produce the private label beverage is a major step toward PURA’s 2019 target of reaching $4 million in revenue.
Read More
Under this agreement, Carlin Group will represent the Company’s to represent its product line to the retail market.
Read More![CURE Pharmaceutical [OTCQB:CURR] and Canopy Growth to Produce CBD Oral Thin Films](https://www.investinweed.com/wp-content/uploads/Cure-Pharmaceutical-627x376.png)
This CUREfilm license gives Canopy a dosage form that is ideal for administering cannabinoids.
Read More
Mr. Yemenidjian has served as Chairman of the Board and Chief Executive Officer of Armenco Holdings, LLC, a private investment company, since January 2005, and co-founded Integral Associates, recently acquired by GTI.
Read More
The agreement with see Wildflower acquire all of the issued and outstanding shares of City Cannabis.
Read More
Get stock alerts, news & related alerts straight to your inbox!